XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $224K invested in XTL Biopharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$2K |
Top Sellers
| 1 |
U
1
UBS
Zurich,
Switzerland
|
$0 |
| 2 |
BRWA
2
B. Riley Wealth Advisors
Boca Raton,
Florida
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $221K | 25,962 | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $2K | 230 | +83 | +56% |
|
3
Ameriprise
Minneapolis,
Minnesota
| $1K | 88 | – | – |
|
|
U
4
UBS
Zurich,
Switzerland
| – | – | -253 | Closed |
|
|
BRWA
5
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | – | -80 | Closed |
|
6
Morgan Stanley
New York
| $0 | 1 | – | – |
|